Global Chronic Urticaria Or Hives Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Chronic Urticaria Or Hives Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Chronic Urticaria Or Hives Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Chronic Urticaria Or Hives Drug market. Chronic Urticaria Or Hives Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Chronic Urticaria Or Hives Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Chronic Urticaria Or Hives Drug market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Chronic Urticaria Or Hives Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Chronic Urticaria Or Hives Drug market. It may include historical data, market segmentation by Type (e.g., GDC-0853, GSK-2646264), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Chronic Urticaria Or Hives Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Chronic Urticaria Or Hives Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Chronic Urticaria Or Hives Drug industry. This include advancements in Chronic Urticaria Or Hives Drug technology, Chronic Urticaria Or Hives Drug new entrants, Chronic Urticaria Or Hives Drug new investment, and other innovations that are shaping the future of Chronic Urticaria Or Hives Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Chronic Urticaria Or Hives Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Chronic Urticaria Or Hives Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Chronic Urticaria Or Hives Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Chronic Urticaria Or Hives Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Chronic Urticaria Or Hives Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Chronic Urticaria Or Hives Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Chronic Urticaria Or Hives Drug market.
Market Segmentation:
Chronic Urticaria Or Hives Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Chronic Urticaria Or Hives Drug market?
What factors are driving Chronic Urticaria Or Hives Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chronic Urticaria Or Hives Drug market opportunities vary by end market size?
How does Chronic Urticaria Or Hives Drug break out type, application?
According to our LPI (LP Information) latest study, the global Chronic Urticaria Or Hives Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Chronic Urticaria Or Hives Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Chronic Urticaria Or Hives Drug market. Chronic Urticaria Or Hives Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Chronic Urticaria Or Hives Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Chronic Urticaria Or Hives Drug market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Chronic Urticaria Or Hives Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Chronic Urticaria Or Hives Drug market. It may include historical data, market segmentation by Type (e.g., GDC-0853, GSK-2646264), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Chronic Urticaria Or Hives Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Chronic Urticaria Or Hives Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Chronic Urticaria Or Hives Drug industry. This include advancements in Chronic Urticaria Or Hives Drug technology, Chronic Urticaria Or Hives Drug new entrants, Chronic Urticaria Or Hives Drug new investment, and other innovations that are shaping the future of Chronic Urticaria Or Hives Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Chronic Urticaria Or Hives Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Chronic Urticaria Or Hives Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Chronic Urticaria Or Hives Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Chronic Urticaria Or Hives Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Chronic Urticaria Or Hives Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Chronic Urticaria Or Hives Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Chronic Urticaria Or Hives Drug market.
Market Segmentation:
Chronic Urticaria Or Hives Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- GDC-0853
- GSK-2646264
- BF-Derm-1
- Bilastine
- Others
- Clinic
- Hospital
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca Plc
- Biofrontera AG
- ELORAC, Inc.
- Faes Farma, SA
- Genentech, Inc.
- GlaxoSmithKline Plc
- J Uriach Y Compania, S.A.
- Mabtech Limited
- Merck & Co., Inc.
- Mycenax Biotech Inc.
- Novartis AG
- Panacea Biotec Limited
What is the 10-year outlook for the global Chronic Urticaria Or Hives Drug market?
What factors are driving Chronic Urticaria Or Hives Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chronic Urticaria Or Hives Drug market opportunities vary by end market size?
How does Chronic Urticaria Or Hives Drug break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chronic Urticaria Or Hives Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Chronic Urticaria Or Hives Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Chronic Urticaria Or Hives Drug by Country/Region, 2019, 2023 & 2030
2.2 Chronic Urticaria Or Hives Drug Segment by Type
2.2.1 GDC-0853
2.2.2 GSK-2646264
2.2.3 BF-Derm-1
2.2.4 Bilastine
2.2.5 Others
2.3 Chronic Urticaria Or Hives Drug Sales by Type
2.3.1 Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Chronic Urticaria Or Hives Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Chronic Urticaria Or Hives Drug Sale Price by Type (2019-2024)
2.4 Chronic Urticaria Or Hives Drug Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.4.3 Others
2.5 Chronic Urticaria Or Hives Drug Sales by Application
2.5.1 Global Chronic Urticaria Or Hives Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Chronic Urticaria Or Hives Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Chronic Urticaria Or Hives Drug Sale Price by Application (2019-2024)
3 GLOBAL CHRONIC URTICARIA OR HIVES DRUG BY COMPANY
3.1 Global Chronic Urticaria Or Hives Drug Breakdown Data by Company
3.1.1 Global Chronic Urticaria Or Hives Drug Annual Sales by Company (2019-2024)
3.1.2 Global Chronic Urticaria Or Hives Drug Sales Market Share by Company (2019-2024)
3.2 Global Chronic Urticaria Or Hives Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Chronic Urticaria Or Hives Drug Revenue by Company (2019-2024)
3.2.2 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Company (2019-2024)
3.3 Global Chronic Urticaria Or Hives Drug Sale Price by Company
3.4 Key Manufacturers Chronic Urticaria Or Hives Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chronic Urticaria Or Hives Drug Product Location Distribution
3.4.2 Players Chronic Urticaria Or Hives Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CHRONIC URTICARIA OR HIVES DRUG BY GEOGRAPHIC REGION
4.1 World Historic Chronic Urticaria Or Hives Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Chronic Urticaria Or Hives Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Chronic Urticaria Or Hives Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Chronic Urticaria Or Hives Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Chronic Urticaria Or Hives Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Chronic Urticaria Or Hives Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Chronic Urticaria Or Hives Drug Sales Growth
4.4 APAC Chronic Urticaria Or Hives Drug Sales Growth
4.5 Europe Chronic Urticaria Or Hives Drug Sales Growth
4.6 Middle East & Africa Chronic Urticaria Or Hives Drug Sales Growth
5 AMERICAS
5.1 Americas Chronic Urticaria Or Hives Drug Sales by Country
5.1.1 Americas Chronic Urticaria Or Hives Drug Sales by Country (2019-2024)
5.1.2 Americas Chronic Urticaria Or Hives Drug Revenue by Country (2019-2024)
5.2 Americas Chronic Urticaria Or Hives Drug Sales by Type
5.3 Americas Chronic Urticaria Or Hives Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chronic Urticaria Or Hives Drug Sales by Region
6.1.1 APAC Chronic Urticaria Or Hives Drug Sales by Region (2019-2024)
6.1.2 APAC Chronic Urticaria Or Hives Drug Revenue by Region (2019-2024)
6.2 APAC Chronic Urticaria Or Hives Drug Sales by Type
6.3 APAC Chronic Urticaria Or Hives Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Chronic Urticaria Or Hives Drug by Country
7.1.1 Europe Chronic Urticaria Or Hives Drug Sales by Country (2019-2024)
7.1.2 Europe Chronic Urticaria Or Hives Drug Revenue by Country (2019-2024)
7.2 Europe Chronic Urticaria Or Hives Drug Sales by Type
7.3 Europe Chronic Urticaria Or Hives Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chronic Urticaria Or Hives Drug by Country
8.1.1 Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Chronic Urticaria Or Hives Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Type
8.3 Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chronic Urticaria Or Hives Drug
10.3 Manufacturing Process Analysis of Chronic Urticaria Or Hives Drug
10.4 Industry Chain Structure of Chronic Urticaria Or Hives Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chronic Urticaria Or Hives Drug Distributors
11.3 Chronic Urticaria Or Hives Drug Customer
12 WORLD FORECAST REVIEW FOR CHRONIC URTICARIA OR HIVES DRUG BY GEOGRAPHIC REGION
12.1 Global Chronic Urticaria Or Hives Drug Market Size Forecast by Region
12.1.1 Global Chronic Urticaria Or Hives Drug Forecast by Region (2025-2030)
12.1.2 Global Chronic Urticaria Or Hives Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Chronic Urticaria Or Hives Drug Forecast by Type
12.7 Global Chronic Urticaria Or Hives Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca Plc
13.1.1 AstraZeneca Plc Company Information
13.1.2 AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 AstraZeneca Plc Main Business Overview
13.1.5 AstraZeneca Plc Latest Developments
13.2 Biofrontera AG
13.2.1 Biofrontera AG Company Information
13.2.2 Biofrontera AG Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Biofrontera AG Main Business Overview
13.2.5 Biofrontera AG Latest Developments
13.3 ELORAC, Inc.
13.3.1 ELORAC, Inc. Company Information
13.3.2 ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 ELORAC, Inc. Main Business Overview
13.3.5 ELORAC, Inc. Latest Developments
13.4 Faes Farma, SA
13.4.1 Faes Farma, SA Company Information
13.4.2 Faes Farma, SA Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Faes Farma, SA Main Business Overview
13.4.5 Faes Farma, SA Latest Developments
13.5 Genentech, Inc.
13.5.1 Genentech, Inc. Company Information
13.5.2 Genentech, Inc. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Genentech, Inc. Main Business Overview
13.5.5 Genentech, Inc. Latest Developments
13.6 GlaxoSmithKline Plc
13.6.1 GlaxoSmithKline Plc Company Information
13.6.2 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 GlaxoSmithKline Plc Main Business Overview
13.6.5 GlaxoSmithKline Plc Latest Developments
13.7 J Uriach Y Compania, S.A.
13.7.1 J Uriach Y Compania, S.A. Company Information
13.7.2 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 J Uriach Y Compania, S.A. Main Business Overview
13.7.5 J Uriach Y Compania, S.A. Latest Developments
13.8 Mabtech Limited
13.8.1 Mabtech Limited Company Information
13.8.2 Mabtech Limited Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Mabtech Limited Main Business Overview
13.8.5 Mabtech Limited Latest Developments
13.9 Merck & Co., Inc.
13.9.1 Merck & Co., Inc. Company Information
13.9.2 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Merck & Co., Inc. Main Business Overview
13.9.5 Merck & Co., Inc. Latest Developments
13.10 Mycenax Biotech Inc.
13.10.1 Mycenax Biotech Inc. Company Information
13.10.2 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Mycenax Biotech Inc. Main Business Overview
13.10.5 Mycenax Biotech Inc. Latest Developments
13.11 Novartis AG
13.11.1 Novartis AG Company Information
13.11.2 Novartis AG Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.11.3 Novartis AG Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Novartis AG Main Business Overview
13.11.5 Novartis AG Latest Developments
13.12 Panacea Biotec Limited
13.12.1 Panacea Biotec Limited Company Information
13.12.2 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Panacea Biotec Limited Main Business Overview
13.12.5 Panacea Biotec Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chronic Urticaria Or Hives Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Chronic Urticaria Or Hives Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Chronic Urticaria Or Hives Drug by Country/Region, 2019, 2023 & 2030
2.2 Chronic Urticaria Or Hives Drug Segment by Type
2.2.1 GDC-0853
2.2.2 GSK-2646264
2.2.3 BF-Derm-1
2.2.4 Bilastine
2.2.5 Others
2.3 Chronic Urticaria Or Hives Drug Sales by Type
2.3.1 Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Chronic Urticaria Or Hives Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Chronic Urticaria Or Hives Drug Sale Price by Type (2019-2024)
2.4 Chronic Urticaria Or Hives Drug Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.4.3 Others
2.5 Chronic Urticaria Or Hives Drug Sales by Application
2.5.1 Global Chronic Urticaria Or Hives Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Chronic Urticaria Or Hives Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Chronic Urticaria Or Hives Drug Sale Price by Application (2019-2024)
3 GLOBAL CHRONIC URTICARIA OR HIVES DRUG BY COMPANY
3.1 Global Chronic Urticaria Or Hives Drug Breakdown Data by Company
3.1.1 Global Chronic Urticaria Or Hives Drug Annual Sales by Company (2019-2024)
3.1.2 Global Chronic Urticaria Or Hives Drug Sales Market Share by Company (2019-2024)
3.2 Global Chronic Urticaria Or Hives Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Chronic Urticaria Or Hives Drug Revenue by Company (2019-2024)
3.2.2 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Company (2019-2024)
3.3 Global Chronic Urticaria Or Hives Drug Sale Price by Company
3.4 Key Manufacturers Chronic Urticaria Or Hives Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chronic Urticaria Or Hives Drug Product Location Distribution
3.4.2 Players Chronic Urticaria Or Hives Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CHRONIC URTICARIA OR HIVES DRUG BY GEOGRAPHIC REGION
4.1 World Historic Chronic Urticaria Or Hives Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Chronic Urticaria Or Hives Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Chronic Urticaria Or Hives Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Chronic Urticaria Or Hives Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Chronic Urticaria Or Hives Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Chronic Urticaria Or Hives Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Chronic Urticaria Or Hives Drug Sales Growth
4.4 APAC Chronic Urticaria Or Hives Drug Sales Growth
4.5 Europe Chronic Urticaria Or Hives Drug Sales Growth
4.6 Middle East & Africa Chronic Urticaria Or Hives Drug Sales Growth
5 AMERICAS
5.1 Americas Chronic Urticaria Or Hives Drug Sales by Country
5.1.1 Americas Chronic Urticaria Or Hives Drug Sales by Country (2019-2024)
5.1.2 Americas Chronic Urticaria Or Hives Drug Revenue by Country (2019-2024)
5.2 Americas Chronic Urticaria Or Hives Drug Sales by Type
5.3 Americas Chronic Urticaria Or Hives Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chronic Urticaria Or Hives Drug Sales by Region
6.1.1 APAC Chronic Urticaria Or Hives Drug Sales by Region (2019-2024)
6.1.2 APAC Chronic Urticaria Or Hives Drug Revenue by Region (2019-2024)
6.2 APAC Chronic Urticaria Or Hives Drug Sales by Type
6.3 APAC Chronic Urticaria Or Hives Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Chronic Urticaria Or Hives Drug by Country
7.1.1 Europe Chronic Urticaria Or Hives Drug Sales by Country (2019-2024)
7.1.2 Europe Chronic Urticaria Or Hives Drug Revenue by Country (2019-2024)
7.2 Europe Chronic Urticaria Or Hives Drug Sales by Type
7.3 Europe Chronic Urticaria Or Hives Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chronic Urticaria Or Hives Drug by Country
8.1.1 Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Chronic Urticaria Or Hives Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Type
8.3 Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chronic Urticaria Or Hives Drug
10.3 Manufacturing Process Analysis of Chronic Urticaria Or Hives Drug
10.4 Industry Chain Structure of Chronic Urticaria Or Hives Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chronic Urticaria Or Hives Drug Distributors
11.3 Chronic Urticaria Or Hives Drug Customer
12 WORLD FORECAST REVIEW FOR CHRONIC URTICARIA OR HIVES DRUG BY GEOGRAPHIC REGION
12.1 Global Chronic Urticaria Or Hives Drug Market Size Forecast by Region
12.1.1 Global Chronic Urticaria Or Hives Drug Forecast by Region (2025-2030)
12.1.2 Global Chronic Urticaria Or Hives Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Chronic Urticaria Or Hives Drug Forecast by Type
12.7 Global Chronic Urticaria Or Hives Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca Plc
13.1.1 AstraZeneca Plc Company Information
13.1.2 AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 AstraZeneca Plc Main Business Overview
13.1.5 AstraZeneca Plc Latest Developments
13.2 Biofrontera AG
13.2.1 Biofrontera AG Company Information
13.2.2 Biofrontera AG Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Biofrontera AG Main Business Overview
13.2.5 Biofrontera AG Latest Developments
13.3 ELORAC, Inc.
13.3.1 ELORAC, Inc. Company Information
13.3.2 ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 ELORAC, Inc. Main Business Overview
13.3.5 ELORAC, Inc. Latest Developments
13.4 Faes Farma, SA
13.4.1 Faes Farma, SA Company Information
13.4.2 Faes Farma, SA Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Faes Farma, SA Main Business Overview
13.4.5 Faes Farma, SA Latest Developments
13.5 Genentech, Inc.
13.5.1 Genentech, Inc. Company Information
13.5.2 Genentech, Inc. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Genentech, Inc. Main Business Overview
13.5.5 Genentech, Inc. Latest Developments
13.6 GlaxoSmithKline Plc
13.6.1 GlaxoSmithKline Plc Company Information
13.6.2 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 GlaxoSmithKline Plc Main Business Overview
13.6.5 GlaxoSmithKline Plc Latest Developments
13.7 J Uriach Y Compania, S.A.
13.7.1 J Uriach Y Compania, S.A. Company Information
13.7.2 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 J Uriach Y Compania, S.A. Main Business Overview
13.7.5 J Uriach Y Compania, S.A. Latest Developments
13.8 Mabtech Limited
13.8.1 Mabtech Limited Company Information
13.8.2 Mabtech Limited Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Mabtech Limited Main Business Overview
13.8.5 Mabtech Limited Latest Developments
13.9 Merck & Co., Inc.
13.9.1 Merck & Co., Inc. Company Information
13.9.2 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Merck & Co., Inc. Main Business Overview
13.9.5 Merck & Co., Inc. Latest Developments
13.10 Mycenax Biotech Inc.
13.10.1 Mycenax Biotech Inc. Company Information
13.10.2 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Mycenax Biotech Inc. Main Business Overview
13.10.5 Mycenax Biotech Inc. Latest Developments
13.11 Novartis AG
13.11.1 Novartis AG Company Information
13.11.2 Novartis AG Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.11.3 Novartis AG Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Novartis AG Main Business Overview
13.11.5 Novartis AG Latest Developments
13.12 Panacea Biotec Limited
13.12.1 Panacea Biotec Limited Company Information
13.12.2 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
13.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Panacea Biotec Limited Main Business Overview
13.12.5 Panacea Biotec Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Chronic Urticaria Or Hives Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Chronic Urticaria Or Hives Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of GDC-0853
Table 4. Major Players of GSK-2646264
Table 5. Major Players of BF-Derm-1
Table 6. Major Players of Bilastine
Table 7. Major Players of Others
Table 8. Global Chronic Urticaria Or Hives Drug Sales by Type (2019-2024) & (K Pcs)
Table 9. Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2019-2024)
Table 10. Global Chronic Urticaria Or Hives Drug Revenue by Type (2019-2024) & ($ million)
Table 11. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2019-2024)
Table 12. Global Chronic Urticaria Or Hives Drug Sale Price by Type (2019-2024) & (USD/Pcs)
Table 13. Global Chronic Urticaria Or Hives Drug Sales by Application (2019-2024) & (K Pcs)
Table 14. Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2019-2024)
Table 15. Global Chronic Urticaria Or Hives Drug Revenue by Application (2019-2024)
Table 16. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2019-2024)
Table 17. Global Chronic Urticaria Or Hives Drug Sale Price by Application (2019-2024) & (USD/Pcs)
Table 18. Global Chronic Urticaria Or Hives Drug Sales by Company (2019-2024) & (K Pcs)
Table 19. Global Chronic Urticaria Or Hives Drug Sales Market Share by Company (2019-2024)
Table 20. Global Chronic Urticaria Or Hives Drug Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Company (2019-2024)
Table 22. Global Chronic Urticaria Or Hives Drug Sale Price by Company (2019-2024) & (USD/Pcs)
Table 23. Key Manufacturers Chronic Urticaria Or Hives Drug Producing Area Distribution and Sales Area
Table 24. Players Chronic Urticaria Or Hives Drug Products Offered
Table 25. Chronic Urticaria Or Hives Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Chronic Urticaria Or Hives Drug Sales by Geographic Region (2019-2024) & (K Pcs)
Table 29. Global Chronic Urticaria Or Hives Drug Sales Market Share Geographic Region (2019-2024)
Table 30. Global Chronic Urticaria Or Hives Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Chronic Urticaria Or Hives Drug Sales by Country/Region (2019-2024) & (K Pcs)
Table 33. Global Chronic Urticaria Or Hives Drug Sales Market Share by Country/Region (2019-2024)
Table 34. Global Chronic Urticaria Or Hives Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Chronic Urticaria Or Hives Drug Sales by Country (2019-2024) & (K Pcs)
Table 37. Americas Chronic Urticaria Or Hives Drug Sales Market Share by Country (2019-2024)
Table 38. Americas Chronic Urticaria Or Hives Drug Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2019-2024)
Table 40. Americas Chronic Urticaria Or Hives Drug Sales by Type (2019-2024) & (K Pcs)
Table 41. Americas Chronic Urticaria Or Hives Drug Sales by Application (2019-2024) & (K Pcs)
Table 42. APAC Chronic Urticaria Or Hives Drug Sales by Region (2019-2024) & (K Pcs)
Table 43. APAC Chronic Urticaria Or Hives Drug Sales Market Share by Region (2019-2024)
Table 44. APAC Chronic Urticaria Or Hives Drug Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Chronic Urticaria Or Hives Drug Revenue Market Share by Region (2019-2024)
Table 46. APAC Chronic Urticaria Or Hives Drug Sales by Type (2019-2024) & (K Pcs)
Table 47. APAC Chronic Urticaria Or Hives Drug Sales by Application (2019-2024) & (K Pcs)
Table 48. Europe Chronic Urticaria Or Hives Drug Sales by Country (2019-2024) & (K Pcs)
Table 49. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Country (2019-2024)
Table 50. Europe Chronic Urticaria Or Hives Drug Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2019-2024)
Table 52. Europe Chronic Urticaria Or Hives Drug Sales by Type (2019-2024) & (K Pcs)
Table 53. Europe Chronic Urticaria Or Hives Drug Sales by Application (2019-2024) & (K Pcs)
Table 54. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Country (2019-2024) & (K Pcs)
Table 55. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Type (2019-2024) & (K Pcs)
Table 59. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Application (2019-2024) & (K Pcs)
Table 60. Key Market Drivers & Growth Opportunities of Chronic Urticaria Or Hives Drug
Table 61. Key Market Challenges & Risks of Chronic Urticaria Or Hives Drug
Table 62. Key Industry Trends of Chronic Urticaria Or Hives Drug
Table 63. Chronic Urticaria Or Hives Drug Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Chronic Urticaria Or Hives Drug Distributors List
Table 66. Chronic Urticaria Or Hives Drug Customer List
Table 67. Global Chronic Urticaria Or Hives Drug Sales Forecast by Region (2025-2030) & (K Pcs)
Table 68. Global Chronic Urticaria Or Hives Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Chronic Urticaria Or Hives Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 70. Americas Chronic Urticaria Or Hives Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Chronic Urticaria Or Hives Drug Sales Forecast by Region (2025-2030) & (K Pcs)
Table 72. APAC Chronic Urticaria Or Hives Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Chronic Urticaria Or Hives Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 74. Europe Chronic Urticaria Or Hives Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 76. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Chronic Urticaria Or Hives Drug Sales Forecast by Type (2025-2030) & (K Pcs)
Table 78. Global Chronic Urticaria Or Hives Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Chronic Urticaria Or Hives Drug Sales Forecast by Application (2025-2030) & (K Pcs)
Table 80. Global Chronic Urticaria Or Hives Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. AstraZeneca Plc Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 83. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 84. AstraZeneca Plc Main Business
Table 85. AstraZeneca Plc Latest Developments
Table 86. Biofrontera AG Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Biofrontera AG Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 88. Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 89. Biofrontera AG Main Business
Table 90. Biofrontera AG Latest Developments
Table 91. ELORAC, Inc. Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 93. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 94. ELORAC, Inc. Main Business
Table 95. ELORAC, Inc. Latest Developments
Table 96. Faes Farma, SA Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Faes Farma, SA Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 98. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 99. Faes Farma, SA Main Business
Table 100. Faes Farma, SA Latest Developments
Table 101. Genentech, Inc. Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Genentech, Inc. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 103. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 104. Genentech, Inc. Main Business
Table 105. Genentech, Inc. Latest Developments
Table 106. GlaxoSmithKline Plc Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 108. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 109. GlaxoSmithKline Plc Main Business
Table 110. GlaxoSmithKline Plc Latest Developments
Table 111. J Uriach Y Compania, S.A. Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 113. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 114. J Uriach Y Compania, S.A. Main Business
Table 115. J Uriach Y Compania, S.A. Latest Developments
Table 116. Mabtech Limited Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Mabtech Limited Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 118. Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 119. Mabtech Limited Main Business
Table 120. Mabtech Limited Latest Developments
Table 121. Merck & Co., Inc. Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 123. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 124. Merck & Co., Inc. Main Business
Table 125. Merck & Co., Inc. Latest Developments
Table 126. Mycenax Biotech Inc. Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 128. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 129. Mycenax Biotech Inc. Main Business
Table 130. Mycenax Biotech Inc. Latest Developments
Table 131. Novartis AG Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 132. Novartis AG Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 133. Novartis AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 134. Novartis AG Main Business
Table 135. Novartis AG Latest Developments
Table 136. Panacea Biotec Limited Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 137. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 138. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 139. Panacea Biotec Limited Main Business
Table 140. Panacea Biotec Limited Latest Developments
Table 1. Chronic Urticaria Or Hives Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Chronic Urticaria Or Hives Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of GDC-0853
Table 4. Major Players of GSK-2646264
Table 5. Major Players of BF-Derm-1
Table 6. Major Players of Bilastine
Table 7. Major Players of Others
Table 8. Global Chronic Urticaria Or Hives Drug Sales by Type (2019-2024) & (K Pcs)
Table 9. Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2019-2024)
Table 10. Global Chronic Urticaria Or Hives Drug Revenue by Type (2019-2024) & ($ million)
Table 11. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2019-2024)
Table 12. Global Chronic Urticaria Or Hives Drug Sale Price by Type (2019-2024) & (USD/Pcs)
Table 13. Global Chronic Urticaria Or Hives Drug Sales by Application (2019-2024) & (K Pcs)
Table 14. Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2019-2024)
Table 15. Global Chronic Urticaria Or Hives Drug Revenue by Application (2019-2024)
Table 16. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2019-2024)
Table 17. Global Chronic Urticaria Or Hives Drug Sale Price by Application (2019-2024) & (USD/Pcs)
Table 18. Global Chronic Urticaria Or Hives Drug Sales by Company (2019-2024) & (K Pcs)
Table 19. Global Chronic Urticaria Or Hives Drug Sales Market Share by Company (2019-2024)
Table 20. Global Chronic Urticaria Or Hives Drug Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Company (2019-2024)
Table 22. Global Chronic Urticaria Or Hives Drug Sale Price by Company (2019-2024) & (USD/Pcs)
Table 23. Key Manufacturers Chronic Urticaria Or Hives Drug Producing Area Distribution and Sales Area
Table 24. Players Chronic Urticaria Or Hives Drug Products Offered
Table 25. Chronic Urticaria Or Hives Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Chronic Urticaria Or Hives Drug Sales by Geographic Region (2019-2024) & (K Pcs)
Table 29. Global Chronic Urticaria Or Hives Drug Sales Market Share Geographic Region (2019-2024)
Table 30. Global Chronic Urticaria Or Hives Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Chronic Urticaria Or Hives Drug Sales by Country/Region (2019-2024) & (K Pcs)
Table 33. Global Chronic Urticaria Or Hives Drug Sales Market Share by Country/Region (2019-2024)
Table 34. Global Chronic Urticaria Or Hives Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Chronic Urticaria Or Hives Drug Sales by Country (2019-2024) & (K Pcs)
Table 37. Americas Chronic Urticaria Or Hives Drug Sales Market Share by Country (2019-2024)
Table 38. Americas Chronic Urticaria Or Hives Drug Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2019-2024)
Table 40. Americas Chronic Urticaria Or Hives Drug Sales by Type (2019-2024) & (K Pcs)
Table 41. Americas Chronic Urticaria Or Hives Drug Sales by Application (2019-2024) & (K Pcs)
Table 42. APAC Chronic Urticaria Or Hives Drug Sales by Region (2019-2024) & (K Pcs)
Table 43. APAC Chronic Urticaria Or Hives Drug Sales Market Share by Region (2019-2024)
Table 44. APAC Chronic Urticaria Or Hives Drug Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Chronic Urticaria Or Hives Drug Revenue Market Share by Region (2019-2024)
Table 46. APAC Chronic Urticaria Or Hives Drug Sales by Type (2019-2024) & (K Pcs)
Table 47. APAC Chronic Urticaria Or Hives Drug Sales by Application (2019-2024) & (K Pcs)
Table 48. Europe Chronic Urticaria Or Hives Drug Sales by Country (2019-2024) & (K Pcs)
Table 49. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Country (2019-2024)
Table 50. Europe Chronic Urticaria Or Hives Drug Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2019-2024)
Table 52. Europe Chronic Urticaria Or Hives Drug Sales by Type (2019-2024) & (K Pcs)
Table 53. Europe Chronic Urticaria Or Hives Drug Sales by Application (2019-2024) & (K Pcs)
Table 54. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Country (2019-2024) & (K Pcs)
Table 55. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Type (2019-2024) & (K Pcs)
Table 59. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Application (2019-2024) & (K Pcs)
Table 60. Key Market Drivers & Growth Opportunities of Chronic Urticaria Or Hives Drug
Table 61. Key Market Challenges & Risks of Chronic Urticaria Or Hives Drug
Table 62. Key Industry Trends of Chronic Urticaria Or Hives Drug
Table 63. Chronic Urticaria Or Hives Drug Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Chronic Urticaria Or Hives Drug Distributors List
Table 66. Chronic Urticaria Or Hives Drug Customer List
Table 67. Global Chronic Urticaria Or Hives Drug Sales Forecast by Region (2025-2030) & (K Pcs)
Table 68. Global Chronic Urticaria Or Hives Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Chronic Urticaria Or Hives Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 70. Americas Chronic Urticaria Or Hives Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Chronic Urticaria Or Hives Drug Sales Forecast by Region (2025-2030) & (K Pcs)
Table 72. APAC Chronic Urticaria Or Hives Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Chronic Urticaria Or Hives Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 74. Europe Chronic Urticaria Or Hives Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Forecast by Country (2025-2030) & (K Pcs)
Table 76. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Chronic Urticaria Or Hives Drug Sales Forecast by Type (2025-2030) & (K Pcs)
Table 78. Global Chronic Urticaria Or Hives Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Chronic Urticaria Or Hives Drug Sales Forecast by Application (2025-2030) & (K Pcs)
Table 80. Global Chronic Urticaria Or Hives Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. AstraZeneca Plc Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 83. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 84. AstraZeneca Plc Main Business
Table 85. AstraZeneca Plc Latest Developments
Table 86. Biofrontera AG Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Biofrontera AG Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 88. Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 89. Biofrontera AG Main Business
Table 90. Biofrontera AG Latest Developments
Table 91. ELORAC, Inc. Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 93. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 94. ELORAC, Inc. Main Business
Table 95. ELORAC, Inc. Latest Developments
Table 96. Faes Farma, SA Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Faes Farma, SA Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 98. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 99. Faes Farma, SA Main Business
Table 100. Faes Farma, SA Latest Developments
Table 101. Genentech, Inc. Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Genentech, Inc. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 103. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 104. Genentech, Inc. Main Business
Table 105. Genentech, Inc. Latest Developments
Table 106. GlaxoSmithKline Plc Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 108. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 109. GlaxoSmithKline Plc Main Business
Table 110. GlaxoSmithKline Plc Latest Developments
Table 111. J Uriach Y Compania, S.A. Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 113. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 114. J Uriach Y Compania, S.A. Main Business
Table 115. J Uriach Y Compania, S.A. Latest Developments
Table 116. Mabtech Limited Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Mabtech Limited Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 118. Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 119. Mabtech Limited Main Business
Table 120. Mabtech Limited Latest Developments
Table 121. Merck & Co., Inc. Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 123. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 124. Merck & Co., Inc. Main Business
Table 125. Merck & Co., Inc. Latest Developments
Table 126. Mycenax Biotech Inc. Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 128. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 129. Mycenax Biotech Inc. Main Business
Table 130. Mycenax Biotech Inc. Latest Developments
Table 131. Novartis AG Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 132. Novartis AG Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 133. Novartis AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 134. Novartis AG Main Business
Table 135. Novartis AG Latest Developments
Table 136. Panacea Biotec Limited Basic Information, Chronic Urticaria Or Hives Drug Manufacturing Base, Sales Area and Its Competitors
Table 137. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Portfolios and Specifications
Table 138. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 139. Panacea Biotec Limited Main Business
Table 140. Panacea Biotec Limited Latest Developments
LIST OF FIGURES
Figure 1. Picture of Chronic Urticaria Or Hives Drug
Figure 2. Chronic Urticaria Or Hives Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chronic Urticaria Or Hives Drug Sales Growth Rate 2019-2030 (K Pcs)
Figure 7. Global Chronic Urticaria Or Hives Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Chronic Urticaria Or Hives Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of GDC-0853
Figure 10. Product Picture of GSK-2646264
Figure 11. Product Picture of BF-Derm-1
Figure 12. Product Picture of Bilastine
Figure 13. Product Picture of Others
Figure 14. Global Chronic Urticaria Or Hives Drug Sales Market Share by Type in 2023
Figure 15. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2019-2024)
Figure 16. Chronic Urticaria Or Hives Drug Consumed in Clinic
Figure 17. Global Chronic Urticaria Or Hives Drug Market: Clinic (2019-2024) & (K Pcs)
Figure 18. Chronic Urticaria Or Hives Drug Consumed in Hospital
Figure 19. Global Chronic Urticaria Or Hives Drug Market: Hospital (2019-2024) & (K Pcs)
Figure 20. Chronic Urticaria Or Hives Drug Consumed in Others
Figure 21. Global Chronic Urticaria Or Hives Drug Market: Others (2019-2024) & (K Pcs)
Figure 22. Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2023)
Figure 23. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application in 2023
Figure 24. Chronic Urticaria Or Hives Drug Sales Market by Company in 2023 (K Pcs)
Figure 25. Global Chronic Urticaria Or Hives Drug Sales Market Share by Company in 2023
Figure 26. Chronic Urticaria Or Hives Drug Revenue Market by Company in 2023 ($ Million)
Figure 27. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Company in 2023
Figure 28. Global Chronic Urticaria Or Hives Drug Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Chronic Urticaria Or Hives Drug Sales 2019-2024 (K Pcs)
Figure 31. Americas Chronic Urticaria Or Hives Drug Revenue 2019-2024 ($ Millions)
Figure 32. APAC Chronic Urticaria Or Hives Drug Sales 2019-2024 (K Pcs)
Figure 33. APAC Chronic Urticaria Or Hives Drug Revenue 2019-2024 ($ Millions)
Figure 34. Europe Chronic Urticaria Or Hives Drug Sales 2019-2024 (K Pcs)
Figure 35. Europe Chronic Urticaria Or Hives Drug Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa Chronic Urticaria Or Hives Drug Sales 2019-2024 (K Pcs)
Figure 37. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue 2019-2024 ($ Millions)
Figure 38. Americas Chronic Urticaria Or Hives Drug Sales Market Share by Country in 2023
Figure 39. Americas Chronic Urticaria Or Hives Drug Revenue Market Share by Country in 2023
Figure 40. Americas Chronic Urticaria Or Hives Drug Sales Market Share by Type (2019-2024)
Figure 41. Americas Chronic Urticaria Or Hives Drug Sales Market Share by Application (2019-2024)
Figure 42. United States Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC Chronic Urticaria Or Hives Drug Sales Market Share by Region in 2023
Figure 47. APAC Chronic Urticaria Or Hives Drug Revenue Market Share by Regions in 2023
Figure 48. APAC Chronic Urticaria Or Hives Drug Sales Market Share by Type (2019-2024)
Figure 49. APAC Chronic Urticaria Or Hives Drug Sales Market Share by Application (2019-2024)
Figure 50. China Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. India Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Country in 2023
Figure 58. Europe Chronic Urticaria Or Hives Drug Revenue Market Share by Country in 2023
Figure 59. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Type (2019-2024)
Figure 60. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Application (2019-2024)
Figure 61. Germany Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. France Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share by Country in 2023
Figure 67. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share by Application (2019-2024)
Figure 70. Egypt Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Chronic Urticaria Or Hives Drug in 2023
Figure 76. Manufacturing Process Analysis of Chronic Urticaria Or Hives Drug
Figure 77. Industry Chain Structure of Chronic Urticaria Or Hives Drug
Figure 78. Channels of Distribution
Figure 79. Global Chronic Urticaria Or Hives Drug Sales Market Forecast by Region (2025-2030)
Figure 80. Global Chronic Urticaria Or Hives Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Chronic Urticaria Or Hives Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Chronic Urticaria Or Hives Drug Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Chronic Urticaria Or Hives Drug
Figure 2. Chronic Urticaria Or Hives Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chronic Urticaria Or Hives Drug Sales Growth Rate 2019-2030 (K Pcs)
Figure 7. Global Chronic Urticaria Or Hives Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Chronic Urticaria Or Hives Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of GDC-0853
Figure 10. Product Picture of GSK-2646264
Figure 11. Product Picture of BF-Derm-1
Figure 12. Product Picture of Bilastine
Figure 13. Product Picture of Others
Figure 14. Global Chronic Urticaria Or Hives Drug Sales Market Share by Type in 2023
Figure 15. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2019-2024)
Figure 16. Chronic Urticaria Or Hives Drug Consumed in Clinic
Figure 17. Global Chronic Urticaria Or Hives Drug Market: Clinic (2019-2024) & (K Pcs)
Figure 18. Chronic Urticaria Or Hives Drug Consumed in Hospital
Figure 19. Global Chronic Urticaria Or Hives Drug Market: Hospital (2019-2024) & (K Pcs)
Figure 20. Chronic Urticaria Or Hives Drug Consumed in Others
Figure 21. Global Chronic Urticaria Or Hives Drug Market: Others (2019-2024) & (K Pcs)
Figure 22. Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2023)
Figure 23. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application in 2023
Figure 24. Chronic Urticaria Or Hives Drug Sales Market by Company in 2023 (K Pcs)
Figure 25. Global Chronic Urticaria Or Hives Drug Sales Market Share by Company in 2023
Figure 26. Chronic Urticaria Or Hives Drug Revenue Market by Company in 2023 ($ Million)
Figure 27. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Company in 2023
Figure 28. Global Chronic Urticaria Or Hives Drug Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Chronic Urticaria Or Hives Drug Sales 2019-2024 (K Pcs)
Figure 31. Americas Chronic Urticaria Or Hives Drug Revenue 2019-2024 ($ Millions)
Figure 32. APAC Chronic Urticaria Or Hives Drug Sales 2019-2024 (K Pcs)
Figure 33. APAC Chronic Urticaria Or Hives Drug Revenue 2019-2024 ($ Millions)
Figure 34. Europe Chronic Urticaria Or Hives Drug Sales 2019-2024 (K Pcs)
Figure 35. Europe Chronic Urticaria Or Hives Drug Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa Chronic Urticaria Or Hives Drug Sales 2019-2024 (K Pcs)
Figure 37. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue 2019-2024 ($ Millions)
Figure 38. Americas Chronic Urticaria Or Hives Drug Sales Market Share by Country in 2023
Figure 39. Americas Chronic Urticaria Or Hives Drug Revenue Market Share by Country in 2023
Figure 40. Americas Chronic Urticaria Or Hives Drug Sales Market Share by Type (2019-2024)
Figure 41. Americas Chronic Urticaria Or Hives Drug Sales Market Share by Application (2019-2024)
Figure 42. United States Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC Chronic Urticaria Or Hives Drug Sales Market Share by Region in 2023
Figure 47. APAC Chronic Urticaria Or Hives Drug Revenue Market Share by Regions in 2023
Figure 48. APAC Chronic Urticaria Or Hives Drug Sales Market Share by Type (2019-2024)
Figure 49. APAC Chronic Urticaria Or Hives Drug Sales Market Share by Application (2019-2024)
Figure 50. China Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. India Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Country in 2023
Figure 58. Europe Chronic Urticaria Or Hives Drug Revenue Market Share by Country in 2023
Figure 59. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Type (2019-2024)
Figure 60. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Application (2019-2024)
Figure 61. Germany Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. France Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share by Country in 2023
Figure 67. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share by Application (2019-2024)
Figure 70. Egypt Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country Chronic Urticaria Or Hives Drug Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Chronic Urticaria Or Hives Drug in 2023
Figure 76. Manufacturing Process Analysis of Chronic Urticaria Or Hives Drug
Figure 77. Industry Chain Structure of Chronic Urticaria Or Hives Drug
Figure 78. Channels of Distribution
Figure 79. Global Chronic Urticaria Or Hives Drug Sales Market Forecast by Region (2025-2030)
Figure 80. Global Chronic Urticaria Or Hives Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Chronic Urticaria Or Hives Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Chronic Urticaria Or Hives Drug Revenue Market Share Forecast by Application (2025-2030)
